Literature DB >> 26042471

Structural Basis for Enhancement of Carbapenemase Activity in the OXA-51 Family of Class D β-Lactamases.

Clyde A Smith1, Nuno Tiago Antunes2, Nichole K Stewart2, Hilary Frase2, Marta Toth2, Katherine A Kantardjieff3, Sergei Vakulenko2.   

Abstract

Class D β-lactamases of Acinetobacter baumannii are enzymes of the utmost clinical importance, producing resistance to last resort carbapenem antibiotics. Although the OXA-51-like enzymes constitute the largest family of class D β-lactamases, they are poorly studied and their importance in conferring carbapenem resistance is controversial. We present the detailed microbiological, kinetic, and structural characterization of the eponymous OXA-51 β-lactamase. Kinetic studies show that OXA-51 has low catalytic efficiency for carbapenems, primarily due to the low affinity of the enzyme for these substrates. Structural studies demonstrate that this low affinity results from the obstruction of the enzyme active site by the side chain of Trp222, which presents a transient steric barrier to an incoming carbapenem substrate. The Trp222Met substitution relieves this steric hindrance and elevates the affinity of the mutant enzyme for carbapenems by 10-fold, significantly increasing the levels of resistance to these antibiotics. The ability of OXA-51 to evolve into a robust carbapenemase as the result of a single amino acid substitution may, in the near future, elevate the ubiquitous enzymes of the OXA-51 family to the status of the most deleterious A. baumannii carbapenemases, with dire clinical consequences.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26042471      PMCID: PMC4546549          DOI: 10.1021/acschembio.5b00090

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  40 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Acinetobacter: a potential reservoir and dispenser for β-lactamases.

Authors:  Wei-Hua Zhao; Zhi-Qing Hu
Journal:  Crit Rev Microbiol       Date:  2011-10-18       Impact factor: 7.624

Review 3.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Authors:  L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

4.  OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.

Authors:  G Bou; A Oliver; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

5.  Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.

Authors:  Todd A Davies; Anne Marie Queenan; Brian J Morrow; Wenchi Shang; Karen Amsler; Wenping He; A Simon Lynch; Chris Pillar; Robert K Flamm
Journal:  J Antimicrob Chemother       Date:  2011-07-20       Impact factor: 5.790

6.  Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina.

Authors:  S Brown; H K Young; S G B Amyes
Journal:  Clin Microbiol Infect       Date:  2005-01       Impact factor: 8.067

7.  OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.

Authors:  Paul G Higgins; Laurent Poirel; Marlene Lehmann; Patrice Nordmann; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

8.  Class D β-lactamases: are they all carbapenemases?

Authors:  Nuno T Antunes; Toni L Lamoureaux; Marta Toth; Nichole K Stewart; Hilary Frase; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

9.  Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam.

Authors:  Kip-Chumba J Kaitany; Neil V Klinger; Cynthia M June; Maddison E Ramey; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

10.  The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.

Authors:  Ignasi Roca; Paula Espinal; Xavier Vila-Farrés; Jordi Vila
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

View more
  16 in total

1.  The structure of a doripenem-bound OXA-51 class D β-lactamase variant with enhanced carbapenemase activity.

Authors:  Cynthia M June; Taylor J Muckenthaler; Emma C Schroder; Zachary L Klamer; Zdzislaw Wawrzak; Rachel A Powers; Agnieszka Szarecka; David A Leonard
Journal:  Protein Sci       Date:  2016-09-26       Impact factor: 6.725

2.  Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase.

Authors:  Laura Dabos; Pierre Bogaerts; Remy A Bonnin; Agustin Zavala; Pierre Sacré; Bogdan I Iorga; Daniel T Huang; Youri Glupczynski; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

3.  Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.

Authors:  Juan Carlos Vázquez-Ucha; María Maneiro; Marta Martínez-Guitián; John Buynak; Christopher R Bethel; Robert A Bonomo; Germán Bou; Margarita Poza; Concepción González-Bello; Alejandro Beceiro
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

4.  Clinical Variants of the Native Class D β-Lactamase of Acinetobacter baumannii Pose an Emerging Threat through Increased Hydrolytic Activity against Carbapenems.

Authors:  Emma C Schroder; Zachary L Klamer; Aysegul Saral; Kyle A Sugg; Cynthia M June; Troy Wymore; Agnieszka Szarecka; David A Leonard
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Triton X-100 and Increased Volume of Test Bacteria in the Carbapenem Inactivation Method Enhanced the Detection of Carbapenemase-Producing Acinetobacter baumannii Complex Isolates.

Authors:  Minxue Liu; Qifei Song; Lijuan Wu; Mengjiao Li; Zhixing Chen; Mei Kang; Yi Xie
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

6.  Multiple substitutions lead to increased loop flexibility and expanded specificity in Acinetobacter baumannii carbapenemase OXA-239.

Authors:  Thomas M Harper; Cynthia M June; Magdalena A Taracila; Robert A Bonomo; Rachel A Powers; David A Leonard
Journal:  Biochem J       Date:  2018-01-11       Impact factor: 3.857

7.  Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase.

Authors:  Josephine P Werner; Joshua M Mitchell; Magdalena A Taracila; Robert A Bonomo; Rachel A Powers
Journal:  Protein Sci       Date:  2017-02-23       Impact factor: 6.725

8.  Use of Comparative Genomics To Characterize the Diversity of Acinetobacter baumannii Surveillance Isolates in a Health Care Institution.

Authors:  Lalena Wallace; Sean C Daugherty; Sushma Nagaraj; J Kristie Johnson; Anthony D Harris; David A Rasko
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

9.  A surface loop modulates activity of the Bacillus class D β-lactamases.

Authors:  Nichole K Stewart; Monolekha Bhattacharya; Marta Toth; Clyde A Smith; Sergei B Vakulenko
Journal:  J Struct Biol       Date:  2020-06-05       Impact factor: 2.867

10.  Epidemiological and genomic characteristics of Acinetobacter baumannii from different infection sites using comparative genomics.

Authors:  Xingchen Bian; Xiaofen Liu; Xuefei Zhang; Xin Li; Jing Zhang; Huajun Zheng; Sichao Song; Xiang Li; Meiqing Feng
Journal:  BMC Genomics       Date:  2021-07-12       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.